nodes	percent_of_prediction	percent_of_DWPC	metapath
Fomepizole—CAT—endothelium—brain cancer	0.0346	0.0973	CbGeAlD
Fomepizole—CAT—blood vessel—brain cancer	0.0319	0.0897	CbGeAlD
Fomepizole—ADH1B—blood vessel—brain cancer	0.0287	0.0808	CbGeAlD
Fomepizole—CAT—Podofilox—Etoposide—brain cancer	0.0277	1	CbGdCrCtD
Fomepizole—ADH1B—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.0186	0.0546	CbGpPWpGaD
Fomepizole—ADH1C—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.0186	0.0546	CbGpPWpGaD
Fomepizole—ADH1A—pituitary gland—brain cancer	0.0164	0.046	CbGeAlD
Fomepizole—CAT—telencephalon—brain cancer	0.0155	0.0435	CbGeAlD
Fomepizole—ADH1A—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.0154	0.0453	CbGpPWpGaD
Fomepizole—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.0144	0.0421	CbGpPWpGaD
Fomepizole—CAT—Detoxification of Reactive Oxygen Species—SOD2—brain cancer	0.0141	0.0412	CbGpPWpGaD
Fomepizole—CAT—FoxO family signaling—SKP2—brain cancer	0.0133	0.0391	CbGpPWpGaD
Fomepizole—CAT—Oxidative Stress—SOD2—brain cancer	0.0129	0.0379	CbGpPWpGaD
Fomepizole—CAT—gonad—brain cancer	0.0129	0.0363	CbGeAlD
Fomepizole—ADH1A—endocrine gland—brain cancer	0.0127	0.0357	CbGeAlD
Fomepizole—Phlebitis—Carboplatin—brain cancer	0.0126	0.0459	CcSEcCtD
Fomepizole—CAT—pituitary gland—brain cancer	0.0126	0.0354	CbGeAlD
Fomepizole—ADH1A—head—brain cancer	0.0125	0.0352	CbGeAlD
Fomepizole—CAT—medulla oblongata—brain cancer	0.0122	0.0342	CbGeAlD
Fomepizole—Nystagmus—Procarbazine—brain cancer	0.0117	0.0424	CcSEcCtD
Fomepizole—ADH1B—gonad—brain cancer	0.0116	0.0327	CbGeAlD
Fomepizole—ADH1A—central nervous system—brain cancer	0.0114	0.0321	CbGeAlD
Fomepizole—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.0113	0.0332	CbGpPWpGaD
Fomepizole—ADH1B—pituitary gland—brain cancer	0.0113	0.0319	CbGeAlD
Fomepizole—CAT—midbrain—brain cancer	0.0111	0.0312	CbGeAlD
Fomepizole—CAT—Cellular responses to stress—EHMT1—brain cancer	0.011	0.0323	CbGpPWpGaD
Fomepizole—CAT—spinal cord—brain cancer	0.0108	0.0305	CbGeAlD
Fomepizole—Visual disturbance—Lomustine—brain cancer	0.0101	0.0365	CcSEcCtD
Fomepizole—ADH1B—Biological oxidations—CYP2C9—brain cancer	0.0099	0.029	CbGpPWpGaD
Fomepizole—ADH1C—Biological oxidations—CYP2C9—brain cancer	0.0099	0.029	CbGpPWpGaD
Fomepizole—CAT—endocrine gland—brain cancer	0.00976	0.0274	CbGeAlD
Fomepizole—CAT—head—brain cancer	0.00963	0.0271	CbGeAlD
Fomepizole—ADH1A—brain—brain cancer	0.00907	0.0255	CbGeAlD
Fomepizole—CAT—FoxO family signaling—SIRT1—brain cancer	0.00907	0.0266	CbGpPWpGaD
Fomepizole—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.0089	0.0261	CbGpPWpGaD
Fomepizole—CAT—central nervous system—brain cancer	0.00879	0.0247	CbGeAlD
Fomepizole—ADH1B—endocrine gland—brain cancer	0.00879	0.0247	CbGeAlD
Fomepizole—CAT—FoxO family signaling—SOD2—brain cancer	0.00873	0.0256	CbGpPWpGaD
Fomepizole—ADH1B—head—brain cancer	0.00868	0.0244	CbGeAlD
Fomepizole—CAT—cerebellum—brain cancer	0.00859	0.0242	CbGeAlD
Fomepizole—Transaminases increased—Carmustine—brain cancer	0.00857	0.0311	CcSEcCtD
Fomepizole—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00856	0.0251	CbGpPWpGaD
Fomepizole—ADH1A—Biological oxidations—CYP2C9—brain cancer	0.00821	0.024	CbGpPWpGaD
Fomepizole—ADH1B—central nervous system—brain cancer	0.00792	0.0223	CbGeAlD
Fomepizole—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.00703	0.0206	CbGpPWpGaD
Fomepizole—CAT—brain—brain cancer	0.00698	0.0196	CbGeAlD
Fomepizole—CAT—Folate Metabolism—SOD2—brain cancer	0.00688	0.0201	CbGpPWpGaD
Fomepizole—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00676	0.0198	CbGpPWpGaD
Fomepizole—Visual impairment—Lomustine—brain cancer	0.00635	0.0231	CcSEcCtD
Fomepizole—ADH1B—brain—brain cancer	0.00629	0.0177	CbGeAlD
Fomepizole—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00611	0.0179	CbGpPWpGaD
Fomepizole—CAT—Selenium Micronutrient Network—SOD2—brain cancer	0.00546	0.016	CbGpPWpGaD
Fomepizole—Eosinophilia—Procarbazine—brain cancer	0.00518	0.0188	CcSEcCtD
Fomepizole—Drowsiness—Procarbazine—brain cancer	0.00466	0.0169	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—SOD2—brain cancer	0.0046	0.0135	CbGpPWpGaD
Fomepizole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.0046	0.0135	CbGpPWpGaD
Fomepizole—Pain—Carboplatin—brain cancer	0.00458	0.0166	CcSEcCtD
Fomepizole—Phlebitis—Carmustine—brain cancer	0.00439	0.016	CcSEcCtD
Fomepizole—CAT—FoxO family signaling—CTNNB1—brain cancer	0.00439	0.0128	CbGpPWpGaD
Fomepizole—Body temperature increased—Carboplatin—brain cancer	0.00423	0.0154	CcSEcCtD
Fomepizole—Decreased appetite—Lomustine—brain cancer	0.00407	0.0148	CcSEcCtD
Fomepizole—CAT—Folate Metabolism—RELA—brain cancer	0.00398	0.0116	CbGpPWpGaD
Fomepizole—CYP2A6—cerebellum—brain cancer	0.00391	0.011	CbGeAlD
Fomepizole—Flushing—Procarbazine—brain cancer	0.00389	0.0141	CcSEcCtD
Fomepizole—Body temperature increased—Lomustine—brain cancer	0.0037	0.0134	CcSEcCtD
Fomepizole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.0037	0.0108	CbGpPWpGaD
Fomepizole—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00365	0.0107	CbGpPWpGaD
Fomepizole—Drowsiness—Hydroxyurea—brain cancer	0.00361	0.0131	CcSEcCtD
Fomepizole—CAT—Folate Metabolism—IL2—brain cancer	0.00358	0.0105	CbGpPWpGaD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—TP53—brain cancer	0.00358	0.0105	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PIK3CG—brain cancer	0.00341	0.00998	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—APC—brain cancer	0.00341	0.00998	CbGpPWpGaD
Fomepizole—Phlebitis—Etoposide—brain cancer	0.0034	0.0123	CcSEcCtD
Fomepizole—Anaemia—Procarbazine—brain cancer	0.00337	0.0122	CcSEcCtD
Fomepizole—CYP2E1—telencephalon—brain cancer	0.00332	0.00935	CbGeAlD
Fomepizole—CYP2A6—brain—brain cancer	0.00317	0.00893	CbGeAlD
Fomepizole—CAT—Selenium Micronutrient Network—RELA—brain cancer	0.00316	0.00925	CbGpPWpGaD
Fomepizole—Convulsion—Procarbazine—brain cancer	0.00316	0.0115	CcSEcCtD
Fomepizole—Anxiety—Procarbazine—brain cancer	0.00309	0.0112	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—CDK6—brain cancer	0.00309	0.00906	CbGpPWpGaD
Fomepizole—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.003	0.00878	CbGpPWpGaD
Fomepizole—Vomiting—Lomustine—brain cancer	0.00298	0.0108	CcSEcCtD
Fomepizole—Shock—Procarbazine—brain cancer	0.00293	0.0106	CcSEcCtD
Fomepizole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00292	0.00856	CbGpPWpGaD
Fomepizole—Tachycardia—Procarbazine—brain cancer	0.0029	0.0105	CcSEcCtD
Fomepizole—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00288	0.00844	CbGpPWpGaD
Fomepizole—Nausea—Lomustine—brain cancer	0.00278	0.0101	CcSEcCtD
Fomepizole—Hypotension—Procarbazine—brain cancer	0.00278	0.0101	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—CDKN2A—brain cancer	0.00277	0.0081	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—ERBB2—brain cancer	0.00264	0.00775	CbGpPWpGaD
Fomepizole—Somnolence—Procarbazine—brain cancer	0.00264	0.0096	CcSEcCtD
Fomepizole—CYP2E1—medulla oblongata—brain cancer	0.00261	0.00735	CbGeAlD
Fomepizole—Anaemia—Hydroxyurea—brain cancer	0.00261	0.00946	CcSEcCtD
Fomepizole—Decreased appetite—Procarbazine—brain cancer	0.00259	0.00938	CcSEcCtD
Fomepizole—Pain—Procarbazine—brain cancer	0.00254	0.00923	CcSEcCtD
Fomepizole—Visual impairment—Carmustine—brain cancer	0.00252	0.00916	CcSEcCtD
Fomepizole—Pharyngitis—Temozolomide—brain cancer	0.00251	0.00912	CcSEcCtD
Fomepizole—Convulsion—Hydroxyurea—brain cancer	0.00244	0.00887	CcSEcCtD
Fomepizole—Visual impairment—Temozolomide—brain cancer	0.00244	0.00885	CcSEcCtD
Fomepizole—Gastrointestinal pain—Procarbazine—brain cancer	0.00243	0.00883	CcSEcCtD
Fomepizole—Flushing—Carmustine—brain cancer	0.00243	0.00882	CcSEcCtD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00237	0.00694	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—SIRT1—brain cancer	0.00236	0.00691	CbGpPWpGaD
Fomepizole—Body temperature increased—Procarbazine—brain cancer	0.00235	0.00853	CcSEcCtD
Fomepizole—Abdominal pain—Procarbazine—brain cancer	0.00235	0.00853	CcSEcCtD
Fomepizole—Flushing—Temozolomide—brain cancer	0.00235	0.00853	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—CCND1—brain cancer	0.00234	0.00684	CbGpPWpGaD
Fomepizole—CYP2E1—spinal cord—brain cancer	0.00233	0.00655	CbGeAlD
Fomepizole—CAT—Cellular responses to stress—CCNE1—brain cancer	0.00233	0.00682	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—CTNNB1—brain cancer	0.00231	0.00678	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—TP53—brain cancer	0.0023	0.00674	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—SOD2—brain cancer	0.00227	0.00665	CbGpPWpGaD
Fomepizole—Back pain—Carmustine—brain cancer	0.00221	0.00801	CcSEcCtD
Fomepizole—Dysgeusia—Temozolomide—brain cancer	0.00216	0.00783	CcSEcCtD
Fomepizole—Vision blurred—Carmustine—brain cancer	0.00215	0.0078	CcSEcCtD
Fomepizole—Back pain—Temozolomide—brain cancer	0.00213	0.00774	CcSEcCtD
Fomepizole—Anaemia—Carmustine—brain cancer	0.00211	0.00765	CcSEcCtD
Fomepizole—CYP2E1—endocrine gland—brain cancer	0.0021	0.0059	CbGeAlD
Fomepizole—Agitation—Carmustine—brain cancer	0.0021	0.00761	CcSEcCtD
Fomepizole—Vision blurred—Temozolomide—brain cancer	0.00208	0.00754	CcSEcCtD
Fomepizole—CYP2E1—head—brain cancer	0.00207	0.00582	CbGeAlD
Fomepizole—Somnolence—Hydroxyurea—brain cancer	0.00205	0.00743	CcSEcCtD
Fomepizole—Anaemia—Temozolomide—brain cancer	0.00204	0.00739	CcSEcCtD
Fomepizole—Diarrhoea—Procarbazine—brain cancer	0.00203	0.00739	CcSEcCtD
Fomepizole—Dyspepsia—Hydroxyurea—brain cancer	0.00203	0.00735	CcSEcCtD
Fomepizole—Agitation—Temozolomide—brain cancer	0.00202	0.00735	CcSEcCtD
Fomepizole—Decreased appetite—Hydroxyurea—brain cancer	0.002	0.00726	CcSEcCtD
Fomepizole—Vertigo—Temozolomide—brain cancer	0.00198	0.00719	CcSEcCtD
Fomepizole—Convulsion—Carmustine—brain cancer	0.00198	0.00717	CcSEcCtD
Fomepizole—Pain—Hydroxyurea—brain cancer	0.00197	0.00714	CcSEcCtD
Fomepizole—Dizziness—Procarbazine—brain cancer	0.00197	0.00714	CcSEcCtD
Fomepizole—Anxiety—Carmustine—brain cancer	0.00193	0.00702	CcSEcCtD
Fomepizole—Convulsion—Temozolomide—brain cancer	0.00191	0.00693	CcSEcCtD
Fomepizole—Vomiting—Procarbazine—brain cancer	0.00189	0.00686	CcSEcCtD
Fomepizole—CYP2E1—central nervous system—brain cancer	0.00189	0.00532	CbGeAlD
Fomepizole—Flushing—Etoposide—brain cancer	0.00188	0.00682	CcSEcCtD
Fomepizole—Rash—Procarbazine—brain cancer	0.00188	0.00681	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—MYC—brain cancer	0.00187	0.00549	CbGpPWpGaD
Fomepizole—Dermatitis—Procarbazine—brain cancer	0.00187	0.0068	CcSEcCtD
Fomepizole—Anxiety—Temozolomide—brain cancer	0.00187	0.00679	CcSEcCtD
Fomepizole—Headache—Procarbazine—brain cancer	0.00186	0.00676	CcSEcCtD
Fomepizole—CYP2E1—cerebellum—brain cancer	0.00185	0.0052	CbGeAlD
Fomepizole—Body temperature increased—Hydroxyurea—brain cancer	0.00182	0.0066	CcSEcCtD
Fomepizole—Tachycardia—Carmustine—brain cancer	0.00182	0.00659	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—CDK4—brain cancer	0.00178	0.00522	CbGpPWpGaD
Fomepizole—Nausea—Procarbazine—brain cancer	0.00177	0.00641	CcSEcCtD
Fomepizole—Hypotension—Carmustine—brain cancer	0.00174	0.00631	CcSEcCtD
Fomepizole—Dysgeusia—Etoposide—brain cancer	0.00173	0.00627	CcSEcCtD
Fomepizole—Back pain—Etoposide—brain cancer	0.00171	0.00619	CcSEcCtD
Fomepizole—ADH1B—Metabolism—CYP2C9—brain cancer	0.00169	0.00496	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CYP2C9—brain cancer	0.00169	0.00496	CbGpPWpGaD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.00169	0.00494	CbGpPWpGaD
Fomepizole—Somnolence—Carmustine—brain cancer	0.00165	0.006	CcSEcCtD
Fomepizole—Anaemia—Etoposide—brain cancer	0.00163	0.00592	CcSEcCtD
Fomepizole—Decreased appetite—Carmustine—brain cancer	0.00162	0.00587	CcSEcCtD
Fomepizole—Somnolence—Temozolomide—brain cancer	0.0016	0.0058	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.00159	0.00466	CbGpPWpGaD
Fomepizole—Pain—Carmustine—brain cancer	0.00159	0.00578	CcSEcCtD
Fomepizole—Vertigo—Etoposide—brain cancer	0.00158	0.00575	CcSEcCtD
Fomepizole—Dyspepsia—Temozolomide—brain cancer	0.00158	0.00575	CcSEcCtD
Fomepizole—Diarrhoea—Hydroxyurea—brain cancer	0.00157	0.00572	CcSEcCtD
Fomepizole—Decreased appetite—Temozolomide—brain cancer	0.00156	0.00567	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—TP53—brain cancer	0.00154	0.00451	CbGpPWpGaD
Fomepizole—Pain—Temozolomide—brain cancer	0.00154	0.00558	CcSEcCtD
Fomepizole—Convulsion—Etoposide—brain cancer	0.00153	0.00554	CcSEcCtD
Fomepizole—CAT—Metabolism—CYP2C9—brain cancer	0.00152	0.00447	CbGpPWpGaD
Fomepizole—Dizziness—Hydroxyurea—brain cancer	0.00152	0.00553	CcSEcCtD
Fomepizole—Gastrointestinal pain—Carmustine—brain cancer	0.00152	0.00552	CcSEcCtD
Fomepizole—CYP2E1—brain—brain cancer	0.0015	0.00422	CbGeAlD
Fomepizole—Abdominal pain—Carmustine—brain cancer	0.00147	0.00534	CcSEcCtD
Fomepizole—Body temperature increased—Carmustine—brain cancer	0.00147	0.00534	CcSEcCtD
Fomepizole—Gastrointestinal pain—Temozolomide—brain cancer	0.00147	0.00534	CcSEcCtD
Fomepizole—Vomiting—Hydroxyurea—brain cancer	0.00146	0.00531	CcSEcCtD
Fomepizole—Rash—Hydroxyurea—brain cancer	0.00145	0.00527	CcSEcCtD
Fomepizole—Dermatitis—Hydroxyurea—brain cancer	0.00145	0.00526	CcSEcCtD
Fomepizole—Headache—Hydroxyurea—brain cancer	0.00144	0.00523	CcSEcCtD
Fomepizole—ADH1C—Metabolism—BSG—brain cancer	0.00144	0.00422	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—BSG—brain cancer	0.00144	0.00422	CbGpPWpGaD
Fomepizole—Abdominal pain—Temozolomide—brain cancer	0.00142	0.00516	CcSEcCtD
Fomepizole—Body temperature increased—Temozolomide—brain cancer	0.00142	0.00516	CcSEcCtD
Fomepizole—Tachycardia—Etoposide—brain cancer	0.0014	0.0051	CcSEcCtD
Fomepizole—ADH1A—Metabolism—CYP2C9—brain cancer	0.0014	0.00411	CbGpPWpGaD
Fomepizole—Nausea—Hydroxyurea—brain cancer	0.00137	0.00496	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—CDKN2A—brain cancer	0.00136	0.00399	CbGpPWpGaD
Fomepizole—Hypotension—Etoposide—brain cancer	0.00134	0.00488	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—RELA—brain cancer	0.00131	0.00384	CbGpPWpGaD
Fomepizole—CAT—Metabolism—BSG—brain cancer	0.0013	0.0038	CbGpPWpGaD
Fomepizole—Somnolence—Etoposide—brain cancer	0.00128	0.00464	CcSEcCtD
Fomepizole—Diarrhoea—Carmustine—brain cancer	0.00127	0.00462	CcSEcCtD
Fomepizole—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.00126	0.00368	CbGpPWpGaD
Fomepizole—Decreased appetite—Etoposide—brain cancer	0.00125	0.00454	CcSEcCtD
Fomepizole—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.00124	0.00363	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—IDH1—brain cancer	0.00124	0.00363	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—IDH1—brain cancer	0.00124	0.00363	CbGpPWpGaD
Fomepizole—Dizziness—Carmustine—brain cancer	0.00123	0.00447	CcSEcCtD
Fomepizole—Pain—Etoposide—brain cancer	0.00123	0.00447	CcSEcCtD
Fomepizole—Diarrhoea—Temozolomide—brain cancer	0.00123	0.00447	CcSEcCtD
Fomepizole—ADH1A—Metabolism—BSG—brain cancer	0.00119	0.0035	CbGpPWpGaD
Fomepizole—Dizziness—Temozolomide—brain cancer	0.00119	0.00432	CcSEcCtD
Fomepizole—Vomiting—Carmustine—brain cancer	0.00118	0.00429	CcSEcCtD
Fomepizole—Gastrointestinal pain—Etoposide—brain cancer	0.00118	0.00427	CcSEcCtD
Fomepizole—Rash—Carmustine—brain cancer	0.00117	0.00426	CcSEcCtD
Fomepizole—Dermatitis—Carmustine—brain cancer	0.00117	0.00425	CcSEcCtD
Fomepizole—Headache—Carmustine—brain cancer	0.00117	0.00423	CcSEcCtD
Fomepizole—Vomiting—Temozolomide—brain cancer	0.00114	0.00415	CcSEcCtD
Fomepizole—Abdominal pain—Etoposide—brain cancer	0.00114	0.00413	CcSEcCtD
Fomepizole—Body temperature increased—Etoposide—brain cancer	0.00114	0.00413	CcSEcCtD
Fomepizole—Rash—Temozolomide—brain cancer	0.00113	0.00412	CcSEcCtD
Fomepizole—Dermatitis—Temozolomide—brain cancer	0.00113	0.00411	CcSEcCtD
Fomepizole—Headache—Temozolomide—brain cancer	0.00113	0.00409	CcSEcCtD
Fomepizole—CAT—Metabolism—IDH1—brain cancer	0.00111	0.00327	CbGpPWpGaD
Fomepizole—Nausea—Carmustine—brain cancer	0.00111	0.00401	CcSEcCtD
Fomepizole—Nausea—Temozolomide—brain cancer	0.00107	0.00388	CcSEcCtD
Fomepizole—ADH1A—Metabolism—IDH1—brain cancer	0.00103	0.00301	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—VEGFA—brain cancer	0.001	0.00294	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—STAT3—brain cancer	0.000994	0.00291	CbGpPWpGaD
Fomepizole—Diarrhoea—Etoposide—brain cancer	0.000985	0.00357	CcSEcCtD
Fomepizole—ADH1B—Metabolism—ENO2—brain cancer	0.000979	0.00287	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ENO2—brain cancer	0.000979	0.00287	CbGpPWpGaD
Fomepizole—Dizziness—Etoposide—brain cancer	0.000952	0.00345	CcSEcCtD
Fomepizole—Vomiting—Etoposide—brain cancer	0.000915	0.00332	CcSEcCtD
Fomepizole—Rash—Etoposide—brain cancer	0.000907	0.00329	CcSEcCtD
Fomepizole—Dermatitis—Etoposide—brain cancer	0.000906	0.00329	CcSEcCtD
Fomepizole—Headache—Etoposide—brain cancer	0.000901	0.00327	CcSEcCtD
Fomepizole—CAT—Metabolism—ENO2—brain cancer	0.000881	0.00258	CbGpPWpGaD
Fomepizole—Nausea—Etoposide—brain cancer	0.000855	0.0031	CcSEcCtD
Fomepizole—ADH1A—Metabolism—ENO2—brain cancer	0.000811	0.00238	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—TP53—brain cancer	0.000758	0.00222	CbGpPWpGaD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	0.000714	0.00209	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PIK3CG—brain cancer	0.000449	0.00132	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PIK3CG—brain cancer	0.000449	0.00132	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PIK3CG—brain cancer	0.000404	0.00118	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PIK3CG—brain cancer	0.000372	0.00109	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CYP2C9—brain cancer	0.000272	0.000797	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—BSG—brain cancer	0.000231	0.000678	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CYP2C9—brain cancer	0.000215	0.00063	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—IDH1—brain cancer	0.000199	0.000583	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—BSG—brain cancer	0.000183	0.000536	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ENO2—brain cancer	0.000157	0.000461	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—IDH1—brain cancer	0.000157	0.000461	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ENO2—brain cancer	0.000124	0.000364	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PIK3CG—brain cancer	7.22e-05	0.000211	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PIK3CG—brain cancer	5.7e-05	0.000167	CbGpPWpGaD
